Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Microlin Bio Inc.
DescriptionUndisclosed miR-based therapeutic
Molecular Target
Mechanism of Action 
Therapeutic ModalityNucleic acid: Linear RNA: microRNA
Latest Stage of DevelopmentDiscovery
Standard IndicationProstate cancer
Indication DetailsTreat prostate cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today